Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein

Coronavirus disease 2019 caused by the novel human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently a major threat to public health worldwide. To deal with the needs of vaccine, we developed four DNA vaccine candidates against SARS-CoV-2, based on the full-length spike (S) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Heeji, Kim, Se Eun, Lee, Yun Ha, Hwang, Yun-Ho, Kim, Su Hwan, Kim, Mi Young, Chung, Gyung Tae, Kim, You-Jin, Kim, Dokeun, Lee, Jung-Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185170/
https://www.ncbi.nlm.nih.gov/pubmed/35751974
http://dx.doi.org/10.1016/j.virol.2022.06.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185170/
https://www.ncbi.nlm.nih.gov/pubmed/35751974
http://dx.doi.org/10.1016/j.virol.2022.06.006

Ejemplares similares